世界の接続式注射可能型ドラッグデリバリーシステム市場2020-2025:従来型注射装置、自己注射装置、その他

LP Informationが発行した調査報告書(LPI21MA03181)
◆英語タイトル:Global Connected Injectable Drug Delivery Devices Market Growth 2020-2025
◆商品コード:LPI21MA03181
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月
◆ページ数:161
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「接続式注射可能型ドラッグデリバリーシステムの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、従来型注射装置、自己注射装置、その他など、用途別には、糖尿病、心血管疾患、自己免疫疾患、ホルモン補充、神経疾患、依存症、呼吸器疾患、その他などに区分してまとめた調査レポートです。接続式注射可能型ドラッグデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・接続式注射可能型ドラッグデリバリーシステムの世界市場概要(サマリー)
・接続式注射可能型ドラッグデリバリーシステムの企業別販売量・売上
・接続式注射可能型ドラッグデリバリーシステムの企業別市場シェア
・接続式注射可能型ドラッグデリバリーシステムの世界市場規模 2015年-2020年:種類別(従来型注射装置、自己注射装置、その他)
・接続式注射可能型ドラッグデリバリーシステムの世界市場規模 2015年-2020年:用途別(糖尿病、心血管疾患、自己免疫疾患、ホルモン補充、神経疾患、依存症、呼吸器疾患、その他)
・接続式注射可能型ドラッグデリバリーシステムの米州市場規模(アメリカ、カナダ、メキシコなど)
・接続式注射可能型ドラッグデリバリーシステムのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・接続式注射可能型ドラッグデリバリーシステムの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・接続式注射可能型ドラッグデリバリーシステムの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・接続式注射可能型ドラッグデリバリーシステム市場の成長要因・課題・動向
・接続式注射可能型ドラッグデリバリーシステムの世界市場予測 2021年-2025年
・接続式注射可能型ドラッグデリバリーシステムの米州市場予測(アメリカ、カナダ、メキシコなど)
・接続式注射可能型ドラッグデリバリーシステムのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・接続式注射可能型ドラッグデリバリーシステムの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・接続式注射可能型ドラッグデリバリーシステムの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・接続式注射可能型ドラッグデリバリーシステムの世界市場予測:種類別(従来型注射装置、自己注射装置、その他)
・接続式注射可能型ドラッグデリバリーシステムの世界市場予測:用途別(糖尿病、心血管疾患、自己免疫疾患、ホルモン補充、神経疾患、依存症、呼吸器疾患、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Connected Injectable Drug Delivery Devices market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Connected Injectable Drug Delivery Devices business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Connected Injectable Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Connected Injectable Drug Delivery Devices, covering the supply chain analysis, impact assessment to the Connected Injectable Drug Delivery Devices market size growth rate in several scenarios, and the measures to be undertaken by Connected Injectable Drug Delivery Devices companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Conventional Injection Devices
Self-Injection Devices
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Hormones Replacement
Neurology
Addiction
Respiratory Diseases
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Phillips-Medisize
Baxter International
West Pharmaceutical Services
Aterica
Unilife
Biocorp
SHL
Propeller Health
Becton Dickinson
Haselmeier
Antares Pharma
Zogenix
Scandinavian Health
Schott
Terumo Medical
Owen Mumford
Ypsomed

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Connected Injectable Drug Delivery Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Connected Injectable Drug Delivery Devices market by identifying its various subsegments.
Focuses on the key global Connected Injectable Drug Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Connected Injectable Drug Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Connected Injectable Drug Delivery Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Connected Injectable Drug Delivery Devices Consumption 2015-2025
2.1.2 Connected Injectable Drug Delivery Devices Consumption CAGR by Region
2.2 Connected Injectable Drug Delivery Devices Segment by Type
2.2.1 Conventional Injection Devices
2.2.2 Self-Injection Devices
2.2.3 Others
2.3 Connected Injectable Drug Delivery Devices Consumption by Type
2.3.1 Global Connected Injectable Drug Delivery Devices Consumption Market Share by Type (2015-2020)
2.3.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Type (2015-2020)
2.3.3 Global Connected Injectable Drug Delivery Devices Sale Price by Type (2015-2020)
2.4 Connected Injectable Drug Delivery Devices Segment by Application
2.4.1 Diabetes
2.4.2 Cardiovascular Diseases
2.4.3 Autoimmune Diseases
2.4.4 Hormones Replacement
2.4.5 Neurology
2.4.6 Addiction
2.4.7 Respiratory Diseases
2.4.8 Others
2.5 Connected Injectable Drug Delivery Devices Consumption by Application
2.5.1 Global Connected Injectable Drug Delivery Devices Consumption Market Share by Type (2015-2020)
2.5.2 Global Connected Injectable Drug Delivery Devices Value and Market Share by Type (2015-2020)
2.5.3 Global Connected Injectable Drug Delivery Devices Sale Price by Type (2015-2020)

3 Global Connected Injectable Drug Delivery Devices by Company
3.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Company
3.1.1 Global Connected Injectable Drug Delivery Devices Sales by Company (2018-2020)
3.1.2 Global Connected Injectable Drug Delivery Devices Sales Market Share by Company (2018-2020)
3.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Company
3.2.1 Global Connected Injectable Drug Delivery Devices Revenue by Company (2018-2020)
3.2.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Company (2018-2020)
3.3 Global Connected Injectable Drug Delivery Devices Sale Price by Company
3.4 Global Connected Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Connected Injectable Drug Delivery Devices Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Connected Injectable Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Connected Injectable Drug Delivery Devices by Regions
4.1 Connected Injectable Drug Delivery Devices by Regions
4.2 Americas Connected Injectable Drug Delivery Devices Consumption Growth
4.3 APAC Connected Injectable Drug Delivery Devices Consumption Growth
4.4 Europe Connected Injectable Drug Delivery Devices Consumption Growth
4.5 Middle East & Africa Connected Injectable Drug Delivery Devices Consumption Growth

5 Americas
5.1 Americas Connected Injectable Drug Delivery Devices Consumption by Countries
5.1.1 Americas Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020)
5.1.2 Americas Connected Injectable Drug Delivery Devices Value by Countries (2015-2020)
5.2 Americas Connected Injectable Drug Delivery Devices Consumption by Type
5.3 Americas Connected Injectable Drug Delivery Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Connected Injectable Drug Delivery Devices Consumption by Regions
6.1.1 APAC Connected Injectable Drug Delivery Devices Consumption by Regions (2015-2020)
6.1.2 APAC Connected Injectable Drug Delivery Devices Value by Regions (2015-2020)
6.2 APAC Connected Injectable Drug Delivery Devices Consumption by Type
6.3 APAC Connected Injectable Drug Delivery Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Connected Injectable Drug Delivery Devices by Countries
7.1.1 Europe Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020)
7.1.2 Europe Connected Injectable Drug Delivery Devices Value by Countries (2015-2020)
7.2 Europe Connected Injectable Drug Delivery Devices Consumption by Type
7.3 Europe Connected Injectable Drug Delivery Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Connected Injectable Drug Delivery Devices by Countries
8.1.1 Middle East & Africa Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Connected Injectable Drug Delivery Devices Value by Countries (2015-2020)
8.2 Middle East & Africa Connected Injectable Drug Delivery Devices Consumption by Type
8.3 Middle East & Africa Connected Injectable Drug Delivery Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Connected Injectable Drug Delivery Devices Distributors
10.3 Connected Injectable Drug Delivery Devices Customer

11 Global Connected Injectable Drug Delivery Devices Market Forecast
11.1 Global Connected Injectable Drug Delivery Devices Consumption Forecast (2021-2025)
11.2 Global Connected Injectable Drug Delivery Devices Forecast by Regions
11.2.1 Global Connected Injectable Drug Delivery Devices Forecast by Regions (2021-2025)
11.2.2 Global Connected Injectable Drug Delivery Devices Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Connected Injectable Drug Delivery Devices Forecast by Type
11.8 Global Connected Injectable Drug Delivery Devices Forecast by Application

12 Key Players Analysis
12.1 Phillips-Medisize
12.1.1 Company Information
12.1.2 Connected Injectable Drug Delivery Devices Product Offered
12.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Phillips-Medisize Latest Developments
12.2 Baxter International
12.2.1 Company Information
12.2.2 Connected Injectable Drug Delivery Devices Product Offered
12.2.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Baxter International Latest Developments
12.3 West Pharmaceutical Services
12.3.1 Company Information
12.3.2 Connected Injectable Drug Delivery Devices Product Offered
12.3.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 West Pharmaceutical Services Latest Developments
12.4 Aterica
12.4.1 Company Information
12.4.2 Connected Injectable Drug Delivery Devices Product Offered
12.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Aterica Latest Developments
12.5 Unilife
12.5.1 Company Information
12.5.2 Connected Injectable Drug Delivery Devices Product Offered
12.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Unilife Latest Developments
12.6 Biocorp
12.6.1 Company Information
12.6.2 Connected Injectable Drug Delivery Devices Product Offered
12.6.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biocorp Latest Developments
12.7 SHL
12.7.1 Company Information
12.7.2 Connected Injectable Drug Delivery Devices Product Offered
12.7.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 SHL Latest Developments
12.8 Propeller Health
12.8.1 Company Information
12.8.2 Connected Injectable Drug Delivery Devices Product Offered
12.8.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Propeller Health Latest Developments
12.9 Becton Dickinson
12.9.1 Company Information
12.9.2 Connected Injectable Drug Delivery Devices Product Offered
12.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Becton Dickinson Latest Developments
12.10 Haselmeier
12.10.1 Company Information
12.10.2 Connected Injectable Drug Delivery Devices Product Offered
12.10.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Haselmeier Latest Developments
12.11 Antares Pharma
12.11.1 Company Information
12.11.2 Connected Injectable Drug Delivery Devices Product Offered
12.11.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Antares Pharma Latest Developments
12.12 Zogenix
12.12.1 Company Information
12.12.2 Connected Injectable Drug Delivery Devices Product Offered
12.12.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Zogenix Latest Developments
12.13 Scandinavian Health
12.13.1 Company Information
12.13.2 Connected Injectable Drug Delivery Devices Product Offered
12.13.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Scandinavian Health Latest Developments
12.14 Schott
12.14.1 Company Information
12.14.2 Connected Injectable Drug Delivery Devices Product Offered
12.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Schott Latest Developments
12.15 Terumo Medical
12.15.1 Company Information
12.15.2 Connected Injectable Drug Delivery Devices Product Offered
12.15.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Terumo Medical Latest Developments
12.16 Owen Mumford
12.16.1 Company Information
12.16.2 Connected Injectable Drug Delivery Devices Product Offered
12.16.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Owen Mumford Latest Developments
12.17 Ypsomed
12.17.1 Company Information
12.17.2 Connected Injectable Drug Delivery Devices Product Offered
12.17.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Ypsomed Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の接続式注射可能型ドラッグデリバリーシステム市場2020-2025:従来型注射装置、自己注射装置、その他(Global Connected Injectable Drug Delivery Devices Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。